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General Information
Commercially available materials purchased from Energy-Chemical were used as received. Proton nuclear magnetic resonance ( 1 H NMR) spectra were recorded on a Bruker AV 500 (500 MHz) spectrometer. Chemical shifts were recorded in parts per million (ppm, δ) relative to tetramethylsilane (δ 0.00) or chloroform ( = 7.26, singlet) . 1 H NMR splitting patterns are designated as singlet (s), doublet (d), triplet (t), quartet (q), dd (doublet of doublets); m (multiplets), and etc. All first-order splitting patterns were assigned on the basis of the appearance of the multiplet. Splitting patterns that could not be easily interpreted are designated as multiplet (m) or broad (br). Carbon nuclear magnetic resonance ( 13 C NMR) spectra were recorded on a Bruker AV 500 (125 MHz) spectrometer. High resolution mass spectral analysis (HRMS) was performed on Waters Xevo G2-S QTof mass spectrometer. Analytical thin-layer chromatography (TLC) was carried out on with GF 254 silica gel coated plates. Flash column chromatography was carried out using 200−300 mesh silica gel. Melting points are uncorrected. N-alkyl protected isatin derived ketimines were synthesized according to reported method.
1
S2
General procedure for the catalytic synthesis of products 3:
To a dry 4 mL vial equipped with a magnetic stir bar, were added electron-rich arene 1 (0.15 mmol), isatin-derived ketamine 2 (0.1 mmol), 4 Å MS (100 mg, powder), Sc(OTf)3 (0.01 mmol), and anhydrous CH3CN (1 mL). The vial was sealed with a septum and the reaction mixture was stirred at room temperature for another 12 hours. After completion of the reaction (monitored by TLC), the reaction mixture was concentrated under reduced pressure and the residue was subjected to column chromatography using hexane/EtOAc = 4/1 as eluent to afford the desired product 3.
Transformation of 3a to 4:
To a dry 4 mL vial equipped with a magnetic stir bar, were added 3a (50.4 mg, 0.1 mmol) and CH2Cl2 (1 mL), this solution was then cooled to 0˚C and TFA (0.03 mL) was carefully added, the reaction mixture was stirred at 0˚C for another 1 hour. After completion of the reaction (monitored by TLC), the reaction mixture was concentrated under reduced pressure and the residue was subjected to column chromatography using hexane/EtOAc = 1/1 then pure EtOAc as eluent to afford the desired product 4.
References cited in the SI: 1. Yan, W.; Wang, D.; Feng, J.; Li, P.; Zhao, D.; Wang, R. Org. Lett. 2012 Lett. , 14, 2512 Lett. -2515 .
S3
Characterization of products:
tert-Butyl-(1-benzyl-2-oxo-3-(2,4,6-trimethoxyphenyl)indolin-3-yl) carbamate (3a): 41.4 mg, 82% yield, white solid, mp 164-165 o C; 1 H NMR (500 MHz, CDCl3) δ 7.52 (d, J = 7.5 Hz, 2H), 7.36 (d, J = 7 Hz, 1H), 7.32 (t, J = 7.5 Hz, 2H), 7.26 (t, J = 6.5 Hz, 1H), 7.09 (t, J = 7.5 Hz, 1H), 6.87 (t, J = 7.5 Hz, 1H), 6.65 (d, J = 7.5 Hz, 1H), 6.13 (s, 2H), 5.07 (br, 1H), 4.99 (br, 1H), 3.73 (s, 3H), 3.63 (br, 6H), 1.31 (br, 9H); 13 C NMR (125 MHz, CDCl3) δ 176. 6, 160.5, 159.0, 153.6, 143.9, 136.8, 131.4, 128.4, 128.3, 127.7, 127.1, 123.4, 122.0, 108.7, 108.4, 93.1, 79.2, 62.6, 56.3, 55.2, 44.6, 28.3 5, 154.3, 151.7, 149.7, 143.2, 142.8, 136.2, 132.0, 128.6, 128.5, 127.5, 127.5, 124.3, 122.7, 117.7, 108.7, 102.2, 98.9, 80.1, 64.6, 56.7, 56.3, 56 .6, 160.9, 158.4, 154.2, 152.5, 142.7, 136.1, 131.9, 128.7, 128.5, 128.4, 127.4, 124.1, 122.6, 118.8, 108.8, 104.7, 100.1, 80.1, 64.6, 55.6, 55.4, 44.2, 28 1 H NMR (500 MHz, CDCl3) δ 7.36 (d, J = 7 Hz, 1H), 7.30-7.27 (m, 2H), 7.25-7.17 (m, 6H), 7.07 (t, J = 7.5 Hz, 1H), 6.67-6.63 (m, 3H), 5.48 (br, 1H), 5.05 (br, 1H), 2.92 (s, 6H), 1.32 (br, 9H); 13 C NMR (125 MHz, CDCl3) δ 176. 5, 153.9, 150.5, 142.9, 135.9, 129.4, 128.6, 128.5, 127.5, 127.3, 127.0, 124.1, 122.5, 115.4, 112.5, 109.2, 80.3, 64.3, 44.0, 40.4 2, 153.9, 151.3, 142.9, 135.8, 130.7, 128.8, 128.6, 127.7, 127.4, 127.1, 124.2, 122.7, 115.5, 109.3, 80.4, 66.7, 64.4, 48.8, 44.0, 28 13 C NMR (125 MHz, CDCl3) δ 175. 8, 153.8, 142.8, 137.9, 136.0, 128.7, 128.5, 128.1, 127.3, 125.1, 123.5, 122.4, 122.4, 121.7, 119.9, 111.8, 109.6, 109.2, 80.3, 62.0, 44.0, 32.8, 28 1 H NMR (500 MHz, CDCl3) δ 7.51 (d, J = 7.5 Hz, 2H), 7.32 (t, J = 7.5 Hz, 2H), 7.25 (t, J = 7.5 Hz, 1H), 7.15 (s, 1H), 6.88 (t, J = 7.5 Hz, 1H), 6.53 (d, J = 8 Hz, 1H), 6.14 (s, 2H), 5.02 (br, 2H), 3.74 (s, 3H), 3.65 (br, 6H), 2.21 (s, 3H), 1.31 (br, 9H); 13 C NMR (125 MHz, CDCl3) δ 176. 6, 160.4, 159.0, 153.6, 141.5, 136.9, 131.3, 131.2, 128.7, 128.4, 127.7, 127.0, 124.2, 108.8, 108.2, 93.1, 79.2, 62.8, 56.3, 55.3, 44.7, 28.3, 21 4, 160.5, 159.0, 155.4, 153.6, 137.6, 136.9, 132.8, 128.5, 127.6, 127.1, 112.1, 111.5, 108.7, 108.6, 93.1, 79.3, 62.9, 56.4, 55.6, 55.3, 44.8, 28.3 160.7, 159.0, 153.5, 142.5, 136.3, 133.0, 128.5, 128.2, 127.6, 127.2, 127.0, 123.8, 109.4, 107.9, 93.1, 79.5, 62.5, 56.3, 55.3, 44.8, 28.3 160.7, 159.0, 153.5, 143.0, 136.3, 133.4, 131.1, 128.5, 127.6, 127.2, 126.5, 114.5, 109.9, 107.9, 93.1, 79.6, 62.5, 56.4, 55.3, 44.8, 28.3 160.5, 158.9, 153.6, 143.1, 130.9, 128.5, 123.4, 122.5, 108.7, 108.5, 93.1, 79.3, 72.5, 63.0, 56.7, 56.2, 55.3, 28 160.7, 158.5, 154.0, 149.7, 139.8, 128.5, 124.1, 123.3, 114.6, 109.0, 92.9, 83.2, 63.1, 56.4, 55.3, 28 3, 160.4, 142.4, 136.4, 133.4, 128.6, 128.4, 127.5, 127.3, 123.4, 122.5, 110.4, 109.1, 92.4, 61.8, 55.9, 55.3, 43.9, 29.7 
tert-Butyl-(1-methyl-2-oxo-3-(2,4,6-trimethoxyphenyl)indolin-3-yl)
